Read about the acquisition of a potential treatment for sickle cell disease, a toxicity data modeling competition, a Michael J. Fox Foundation grant to NIH, and more.
NCATS chemical screening resources enable studies on potential treatments for Parkinson's and related diseases.
NCATS researchers provided crucial pre-clinical resources for Aes-103, a potential therapeutic to treat sickle cell disease.
NCATS scientists exploring the lipoxygenase enzyme family have enabled development of three chemical probes with the potential to treat diabetes, stroke and thrombosis.
How is NCATS advancing translational research? Learn more about the Center's work and some of its early successes.
MORE CENTER NEWS
Grouping patients by shared disease characteristics enables more targeted treatment.
- The Coming Human Body on a Chip that will Change How We Make Drugs • Fast Company
- Tox21 Team Opens Competition to Predict Toxicity • Chemical Watch (Access requires registration and subscription.)
- Combination Antiretroviral Therapy Helps Treat Hepatitis C in HIV Patients • University of Cincinnati
- More News & Events...